Coursera stock rises on better-than-expected sales forecast
Shares of Coursera Inc. rose after hours on Thursday after the online education platform's full-year sales forecast and first-quarter results came in above Wall Street's expectations and the company announced a stock buyback. Coursera said it expected full-year sales of $600 million to $610 million, compared with FactSet estimates for $600.9 million. First-quarter net loss was $32.4 million, or 22 cents a share, compared with $38.3 million, or 27 cents a share, in the same quarter last year. Revenue was $147.6 million, compared with $120.4 million in the prior-year quarter. Analysts polled by FactSet expected revenue of $138.5 million. Executives also said the company's board approved a share buyback program of up to $95 million, and said the company had added 10 new degree programs intended for working adults. Shares rose 2.2% after hours on Thursday. "The transformation of higher education has never been more urgent," Chief Executive Jeff Maggioncalda said in a statement. "We believe emerging AI technologies will usher in a new era of skilling imperatives for individuals, businesses, and governments globally."
-Bill Peters
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-27-23 1718ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise